abcdefghijklmn
opqrstuvwxyz
Test Menu
Test Change Details
Allergy & Immunology
Cardiology & Coagulation
Dermatopathology
Endocrinology
Gastroenterology
Genetics
Hepatology
Infectious Disease
Microbiology
Nephrology
Neurology
Oncology
Pathology
Pediatrics
Rheumatology
Toxicology
Urology
Women's Health
17161: MDMA/MDA, Quantitative, Urine Print View
MDA MASS SPEC  < 200  ng/mL 
MDMA MASS SPEC  < 200  ng/mL 
MDEA MASS SPEC  < 200  ng/mL 

PRIMARY
1 Urine 20 (5) mL   Frozen - 30 Day(s)/Refrigerated - 14 Day(s)/Room Temperature - 14 Day(s)  
ALTERNATE

This test is designed to detect the use of the stimulant/hallucinogen methylenedioxymethamphetamine (MDMA, XTC, Ecstasy) methylenedioxyethylamphetamine (MDEA), and their metabolite methylenedioxyamphetamine (MDA).

20 mL random urine in a plastic leak proof container, no
preservatives.

Transportation Temperature: Refrigerated
Setup Schedule
Tuesday, Thursday, Saturday

Reported (Analytical Time)
3 days

CPT Code
80359

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Notes
Rejection Criteria: Preserved urine






1996 - 2017 Quest Diagnostics Nichols Institute of Valencia
For test information, please call Client Services at 800-421-4449.

San Francisco Web Design & Database